The National Institute of General Medical Sciences (NIGMS) awarded a $497,317 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Wisconsin System's University of Wisconsin - Madison division, operating as Research and Sponsored Programs, to conduct research on the analysis of bulk lipid transport at membrane contact sites.
The research aims to define the essential molecular properties of the Bridge-Like Lipid Transfer Protein 2 (BLTP2) and investigate how its function at membrane contact sites is regulated. The long-term goal is to understand BLTP function and the impact of bulk lipid transport regulation on animal physiology, with the expectation that the findings will provide insights into the role of BLTPs in human disease and potential new therapies to treat disorders caused by BLTP dysfunction. The grant award period runs from July 19, 2024 to May 31, 2028.
Generated 2/25/25, 1:52 AM